Saag Michael, Balu Rukmini, Phillips Elizabeth, Brachman Philip, Martorell Claudia, Burman William, Stancil Britt, Mosteller Michael, Brothers Cindy, Wannamaker Paul, Hughes Arlene, Sutherland-Phillips Denise, Mallal Simon, Shaefer Mark
Center for AIDS Research, University of Alabama at Birmingham, Birmingham, USA.
Clin Infect Dis. 2008 Apr 1;46(7):1111-8. doi: 10.1086/529382.
Although the human leukocyte antigen (HLA)-B5701 is highly associated with a hypersensitivity reaction (HSR) to abacavir (ABC), variable sensitivities have been reported when clinical data alone have been used to define an ABC HSR. This study evaluated the sensitivity of detection of the HLA-B5701 allele as a marker of ABC HSRs in both white and black patients, using skin patch testing to supplement clinical diagnosis.
White and black patients, identified through chart review, were classified as having received a diagnosis of an ABC HSR based on clinical findings only (a clinically suspected ABC HSR) or based on clinical findings and a positive skin patch test result (an immunologically confirmed [IC] ABC HSR). Control subjects were racially matched subjects who tolerated ABC for >/=12 weeks without experiencing an ABC HSR. Patients and control subjects were tested for the presence of HLA-B5701. Sensitivity, specificity, and odds ratios for the detection of HLA-B5701 as a marker for an ABC HSR were calculated for white and black participants.
Forty-two (32.3%) of 130 white patients and 5 (7.2%) of 69 black patients who met the criteria for clinically suspected HSRs had IC HSRs. All 42 white patients with IC HSRs were HLA-B5701 positive (sensitivity, 100%; odds ratio, 1945; 95% confidence interval, 110-34,352). Among all white patients with clinically suspected HSRs, sensitivity was 44% (57 of 130 patients tested positive for HLA-B5701); specificity among white control subjects was 96%. Five of 5 black patients with IC HSRs were HLA-B5701 positive (sensitivity, 100%; odds ratio, 900; 95% confidence interval, 38-21,045). Among black patients with clinically suspected HSRs, the sensitivity was 14% (10 of 69 tested positive for HLA-B5701); specificity among black control subjects was 99%.
Although IC ABC HSRs are uncommon in black persons, the 100% sensitivity of HLA-B5701 as a marker for IC ABC HSRs in both US white and black patients suggests similar implications of the association between HLA-B5701 positivity and risk of ABC HSRs in both races.
尽管人类白细胞抗原(HLA)-B5701与阿巴卡韦(ABC)超敏反应(HSR)高度相关,但仅使用临床数据来定义ABC HSR时,已报告了不同的敏感性。本研究使用皮肤斑贴试验辅助临床诊断,评估了HLA-B5701等位基因检测作为白人和黑人患者中ABC HSR标志物的敏感性。
通过病历审查确定的白人和黑人患者,根据仅临床发现(临床疑似ABC HSR)或根据临床发现和阳性皮肤斑贴试验结果(免疫确诊[IC]ABC H HHSR)被分类为已接受ABC HSR诊断。对照受试者是种族匹配的受试者,他们耐受ABC≥12周且未经历ABC HSR。对患者和对照受试者进行HLA-B5701检测。计算白人和黑人参与者中检测HLA-B5701作为ABC HSR标志物的敏感性、特异性和比值比。
130名符合临床疑似HSR标准的白人患者中有42名(32.3%)和69名黑人患者中有5名(7.2%)有IC HSR。所有42名有IC HSR的白人患者HLA-B5701均为阳性(敏感性,100%;比值比,1945;95%置信区间,110-34352)。在所有临床疑似HSR的白人患者中,敏感性为44%(130名患者中有57名HLA-B5701检测呈阳性);白人对照受试者中的特异性为96%。5名有IC HSR的黑人患者中有5名HLA-B5701为阳性(敏感性,100%;比值比,900;95%置信区间,38-21045)。在临床疑似HSR的黑人患者中,敏感性为14%(69名中有10名HLA-B5701检测呈阳性);黑人对照受试者中的特异性为99%。
尽管IC ABC HSR在黑人中不常见,但HLA-B5701作为美国白人和黑人患者中IC ABC HSR标志物的100%敏感性表明,HLA-B5701阳性与ABC HSR风险之间的关联在两个种族中具有相似的意义。